Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-E25398-100 100 µg $145 
Blocking Peptide

SF3B130 / SF3B3 Antibody Blocking Peptide - LS-E25398

SF3B130 / SF3B3 Antibody Blocking Peptide - LS-E25398

Description:
For Research Use Only
Q15393 NM_012426 NP_036558.3

Price
Catalog Number
$145
LS-E25398-100
Toll Free North America
206-374-1102
For Research Use Only

Overview

Description:
For Research Use Only
Q15393 NM_012426 NP_036558.3

Specifications

Target
SF3B130 / SF3B3
Synonyms
SF3B3 | RSE1 | Splicing factor 3B subunit 3 | SAP 130 | STAF130 | KIAA0017 | SF3b130
Presentation
Lyophilized
Reconstitution
Reconstitute in distilled water.
Recommended Storage
Store at -20°C.
Usage
LS-E25398 is the immunizing peptide used to generate LS-C55433. Useful for pre-absorption and neutralization of the antibody's antigen binding site.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This blocking peptide carries the LSBio 100% Guarantee

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/19/2024